We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Vaginal Birth After Cesarian Safer than Thought

By HospiMedica staff writers
Posted on 18 Feb 2004
A new study involving 19 academic centers and 46,000 women has demonstrated that while serious complications are possible in giving vaginal birth after a cesarean-section birth, the absolute risk of these occurring is very small.

For years, doctors recommended that women who delivered via cesarean section should not deliver future infants vaginally, but studies over the past 20 years disputed that belief and many women have chosen to undergo vaginal birth after cesarean section (VBAC). More...
While this new four-year study shows that women attempting VBAC are at increased risk for maternal morbidity and serious obstetric complications, such as uterine rupture, endometritis, transfusion, or newborn hypoxic ischemic encephalopathy, the risks are small.

"While the magnitude of these risks is small, women who have had a previous cesarean section and who are considering choices for childbirth should be aware of the level of risk involved,” said principal investigator Dr. Mark Landon, vice chairman of obstetrics and gynecology at the Ohio State University Medical Center (Columbus, USA). "Overall, the risk for a serious newborn complication is approximately one in 2,000 trials of labor. At this level of risk, many women will continue to opt for an attempted VBAC.”

The overall rate of cesarean delivery has risen in the United States from 5% in 1970 to 26.1% in 2002. The rate of VBAC has increased 10-fold, from 3% in 1981 to 31% in 1998.



Related Links:
Ohio State University Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.